Update on Commercial Terms for the Proposed Merger with MAP
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Under the new terms, Microba shareholders will hold a larger percentage of the merged entity compared to previous proposals, while existing Genetic Signatures shareholders will hold a smaller percentage. The announcement confirms that all other material terms of the merger remain unchanged and that the transaction is progressing as planned.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Genetic Signatures Ltd. on 6ix
Earlier from Genetic Signatures
- Response to Media Speculation & BCAL letter to GSS
- GSS: Response to Media Speculation & BCAL letter to GSS
- 2026 Notice of Annual General Meeting
- Quarterly Activities/Appendix 4C Cash Flow Report
- Becoming a substantial holder
Later from Genetic Signatures
- Addendum to Notice of Annual General Meeting
- Results of 2026 EGM and Appointment of Director
- BCAL Welcomes Dr John Melki's Appointment to GSS Board
- 3X Initial Directors Interest Notice
- Notification regarding unquoted securities - GSS
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures